Skip to main content
Normal View

Covid-19 Pandemic

Dáil Éireann Debate, Tuesday - 9 November 2021

Tuesday, 9 November 2021

Questions (593, 684)

Mattie McGrath

Question:

593. Deputy Mattie McGrath asked the Minister for Health his proposals to allow those who, on medical grounds, are not fully vaccinated to be allowed to fully participate in society; if he will introduce an exemption to the current Covid-19 restrictions, on health grounds; and if he will make a statement on the matter. [54241/21]

View answer

Jim O'Callaghan

Question:

684. Deputy Jim O'Callaghan asked the Minister for Health the steps he is taking to permit antigen testing as a means of facilitating access to hospitality for persons who cannot get vaccinated on medical grounds; and if he will make a statement on the matter. [54750/21]

View answer

Written answers

I propose to take Questions Nos. 593 and 684 together.

The current high level of COVID-19 infection and the dominance of the significantly more transmissible Delta variant poses a very substantial threat, particularly to those who are not fully protected through vaccination. Public health advice remains that those who are not fully vaccinated should avoid congregated indoor settings for their own and others safety.

The National Public Health Emergency Team gave some consideration to the issues arising for those people that can’t receive a COVID-19 vaccine for medical reasons as part of its discussions on the 18th October 2021 on the continuing response to COVID-19 and the extension of Covid Pass arrangements. The matter is being given further consideration.

The Deputies may wish to be aware that on 15 July, NIAC made a recommendation, which was endorsed by the Chief Medical Officer and accepted by the Minister for Health that while the preference was for homologous vaccination regimens (using the same vaccine as part of a two dose regime) that selective use of heterologous vaccination schedules (two different vaccines used as part of two dose regime) should be permitted where a second vaccine dose of a homologous regimen is contraindicated, irrespective of whether the first dose was an mRNA or adenoviral vector vaccine. NIAC in conjunction with the RCPI and the Irish Association of Allergy and Immunology have prepared a guide to aid vaccinators and other healthcare workers on how to advise allergic individuals in respect of receiving a COVID-19 vaccine, this guide is available here: rcpi-live-cdn.s3.amazonaws.com/wp-content/uploads/2021/08/FAQs-about-COVID19-Vaccines-and-Allergies_12August2021.pdf

Top
Share